These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36765790)

  • 1. Circulating Tumor Cell Enumeration for Serial Monitoring of Treatment Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
    Ko JMY; Lam KO; Kwong DLW; Wong IY; Chan FS; Wong CL; Chan KK; Law TT; Chiu KWH; Lam CCS; Wong JC; Fong HCH; Choy FSF; Lo A; Law S; Lung ML
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma.
    Ko JMY; Ng HY; Lam KO; Chiu KWH; Kwong DLW; Lo AWI; Wong JC; Lin RCW; Fong HCH; Li JYK; Dai W; Law S; Lung ML
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.
    Cohen EN; Jayachandran G; Gao H; Peabody P; McBride HB; Alvarez FD; Bravo PL; Qiao W; Liu S; Yao L; Lin SH; Reuben JM
    Transl Lung Cancer Res; 2023 Jan; 12(1):109-126. PubMed ID: 36762061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
    Qiao Y; Li J; Shi C; Wang W; Qu X; Xiong M; Sun Y; Li D; Zhao X; Zhang D
    Onco Targets Ther; 2017; 10():1363-1373. PubMed ID: 28424552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy.
    Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD
    Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene Profiling of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma Identifies Prognostic Cancer Driver Genes Associated with Epithelial-Mesenchymal-Transition Progression and Chemoresistance.
    Tan Z; Ko JM; Yu VZ; Lam KO; Kwong DL; Wong IY; Chan FS; Wong CL; Chan KK; Law TT; Choy FS; Ng HY; Law SY; Lung ML
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer.
    Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F
    Front Oncol; 2021; 11():602222. PubMed ID: 34150608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma: Cancer-Draining Blood Versus Peripheral Blood.
    Joo DC; Kim GH; I H; Park SJ; Lee MW; Lee BE
    Cancers (Basel); 2024 Aug; 16(16):. PubMed ID: 39199691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
    Han L; Li YJ; Zhang WD; Song PP; Li H; Li S
    Medicine (Baltimore); 2019 Feb; 98(6):e13921. PubMed ID: 30732126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer.
    Li Z; Fan L; Wu Y; Niu Y; Zhang X; Wang B; Yao Y; Chen C; Qi N; Wang DD; Lin PP; Tang D; Gao W
    J Thorac Dis; 2022 May; 14(5):1544-1555. PubMed ID: 35693614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
    Chen W; Li Y; Yuan D; Peng Y; Qin J
    Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.
    Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH
    World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
    Davies CR; Guo T; Burke E; Stankiewicz E; Xu L; Mao X; Scandura G; Rajan P; Tipples K; Alifrangis C; Wimalasingham AG; Galazi M; Crusz S; Powles T; Grey A; Oliver T; Kudahetti S; Shaw G; Berney D; Shamash J; Lu YJ
    Front Oncol; 2022; 12():1060864. PubMed ID: 36727071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.